Investor Relations

Investor Presentation

View our latest Investor Presentation to find the most recent investor-related information.

Investor Relations

Latest Presentation

Investor Presentation

Latest Event

Annual Meeting of Shareholders

Company Overview

Virax Biolabs is a Biotech and disruptive Medical Technology company focused on the prevention, detection and diagnosis of Viral threats. Our mission is the global provision of high-quality diagnostic kits, particularly T-Cell tests, which accurately and effectively predict an individual's immune response to significant viral threats. Our proprietary diagnostic T-cell technologies are virus agnostic, offering high levels of transparency, information and insight in a cost-efficient way. Key product ranges include ViraxClear, ViraxCare and flagship product being released 2022, Virax Immune.

IR Contacts


Virax Biolabs Group Limited
20 North Audley Street
London W1K 6LX
United Kingdom
T: +44 20 7788 7414

Investor Relations

Russo Partners, LLC
Maxim Jacobs, CFA
12 West 27th Street
4th Floor
New York, NY 10001
M: 646-942-5591

Transfer Agent

Continental Stock Transfer
Charlotte Hewitt
1 State Street
30th Floor
New York, NY 10004
T: 212-857-7577